INS and fatty liver disease: In contrast, in KK-Ay mice fed high-fat diet (a model for T2D possessing insulin resistance), dietary supplementation with EA (0.1%) for 68 days did not affect serum glucose or insulin, although it reduced serum resistin and improved serum lipid profile and hepatic steatosis [59].